Latest news
Loading news…
Alcyone Therapeutics is Pioneering Next-Generation Precision CNS Genetic Therapies to unlock new possibilities
Alcyone Therapeutics was acquired by Biogen in 2025 for $85M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
31
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Lowell, Massachusetts, United States
Key People at Alcyone Therapeutics
President and CEO
Head of R&D, Precision Delivery
31
professional contacts at Alcyone Therapeutics
Contact execs at Alcyone Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Alcyone Therapeutics
Loading news…
FAQs about Alcyone Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.